Literature DB >> 22265420

EMT and dissemination precede pancreatic tumor formation.

Andrew D Rhim1, Emily T Mirek, Nicole M Aiello, Anirban Maitra, Jennifer M Bailey, Florencia McAllister, Maximilian Reichert, Gregory L Beatty, Anil K Rustgi, Robert H Vonderheide, Steven D Leach, Ben Z Stanger.   

Abstract

Metastasis is the leading cause of cancer-associated death but has been difficult to study because it involves a series of rare, stochastic events. To capture these events, we developed a sensitive method to tag and track pancreatic epithelial cells in a mouse model of pancreatic cancer. Tagged cells invaded and entered the bloodstream unexpectedly early, before frank malignancy could be detected by rigorous histologic analysis; this behavior was widely associated with epithelial-to-mesenchymal transition (EMT). Circulating pancreatic cells maintained a mesenchymal phenotype, exhibited stem cell properties, and seeded the liver. EMT and invasiveness were most abundant at inflammatory foci, and induction of pancreatitis increased the number of circulating pancreatic cells. Conversely, treatment with the immunosuppressive agent dexamethasone abolished dissemination. These results provide insight into the earliest events of cellular invasion in situ and suggest that inflammation enhances cancer progression in part by facilitating EMT and entry into the circulation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22265420      PMCID: PMC3266542          DOI: 10.1016/j.cell.2011.11.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  47 in total

1.  Introduction: unknown primary cancer.

Authors:  F Anthony Greco; John D Hainsworth
Journal:  Semin Oncol       Date:  2009-02       Impact factor: 4.929

2.  The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.

Authors:  Simone Brabletz; Karolina Bajdak; Simone Meidhof; Ulrike Burk; Gabriele Niedermann; Elke Firat; Ulrich Wellner; Arno Dimmler; Gerhard Faller; Jörg Schubert; Thomas Brabletz
Journal:  EMBO J       Date:  2011-01-11       Impact factor: 11.598

3.  Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene.

Authors:  Douglas B Stairs; Lauren J Bayne; Ben Rhoades; Maria E Vega; Todd J Waldron; Jiri Kalabis; Andres Klein-Szanto; Ju-Seog Lee; Jonathan P Katz; J Alan Diehl; Albert B Reynolds; Robert H Vonderheide; Anil K Rustgi
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.

Authors:  R M Mohammad; M C Dugan; A N Mohamed; V P Almatchy; T M Flake; S T Dergham; A F Shields; A A Al-Katib; V K Vaitkevicius; F H Sarkar
Journal:  Pancreas       Date:  1998-01       Impact factor: 3.327

5.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

View more
  870 in total

1.  Navigating uncharted territory.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

Review 2.  Circulating tumor cells in the diagnosis and management of pancreatic cancer.

Authors:  Putao Cen; Xiaoling Ni; Jingxuan Yang; David Y Graham; Min Li
Journal:  Biochim Biophys Acta       Date:  2012-06-07

3.  Unusual early-stage pancreatic sarcomatoid carcinoma.

Authors:  Chuan-Li Ren; Ping Jin; Chong-Xu Han; Qin Xiao; Dao-Rong Wang; Lin Shi; Da-Xin Wang; Hui Chen
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 4.  Tracking cells in their native habitat: lineage tracing in epithelial neoplasia.

Authors:  Maria P Alcolea; Philip H Jones
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

5.  Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma.

Authors:  Justin G Wilkes; Brianne R O'Leary; Juan Du; Adrienne R Klinger; Zita A Sibenaller; Claire M Doskey; Katherine N Gibson-Corley; Matthew S Alexander; Susan Tsai; Garry R Buettner; Joseph J Cullen
Journal:  Clin Exp Metastasis       Date:  2018-02-02       Impact factor: 5.150

6.  EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas.

Authors:  Alexcia Camila Braun; Celso Abdon Lopes de Mello; Marcelo Corassa; Emne Ali Abdallah; Ana Cláudia Urvanegia; Vanessa Silva Alves; Bianca C T C P Flores; Mônica Díaz; Ulisses Ribaldo Nicolau; Virgilio Souza E Silva; Vinicius Calsavara; Patrizia Paterlini-Brechót; Ludmilla Thomé Domingos Chinen
Journal:  Cancer Biol Ther       Date:  2018-03-21       Impact factor: 4.742

7.  Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma.

Authors:  Guangdong Wu; Rongrong Zhu; Yatong Li; Yupei Zhao; Menghua Dai
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

8.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 9.  Life history trade-offs in cancer evolution.

Authors:  C Athena Aktipis; Amy M Boddy; Robert A Gatenby; Joel S Brown; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2013-11-11       Impact factor: 60.716

10.  Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Authors:  Tao Yin; Guoping Wang; Sisi He; Guobo Shen; Chao Su; Yan Zhang; Xiawei Wei; Tinghong Ye; Ling Li; Shengyong Yang; Dan Li; Fuchun Guo; Zeming Mo; Yang Wan; Ping Ai; Xiaojuan Zhou; Yantong Liu; Yongsheng Wang; Yuquan Wei
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.